CoChat

Polygenic risk and hazard scores for Alzheimer's disease prediction

Open access
Leonenko, Ganna, Sims, Rebecca, Shoai, Maryam, Frizzati, Aura, Bossù, Paola, Spalletta, Gianfranco, Fox, Nick C., Williams, Julie, the GERAD consortium, Hardy, John, Escott‐Price, Valentina · 2019 · Annals of Clinical and Translational Neurology
Cited by 95

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Objective: Genome‐wide association studies (GWAS) have identified over 30 susceptibility loci associated with Alzheimer's disease (AD). Using AD GWAS data from the International Genomics of Alzheimer's Project (IGAP), Polygenic Risk Score (PRS) was successfully applied to predict life time risk of AD development. A recently introduced Polygenic Hazard Score (PHS) is able to quantify individuals with age‐specific genetic risk for AD. The aim of this study was to quantify the age‐specific genetic risk for AD with PRS and compare the results generated by PRS with those from PHS. Methods: Quantification of individual differences in age‐specific genetic risk for AD identified by the PRS, was performed with Cox Regression on 9903 (2626 cases and 7277 controls) individuals from the Genetic and Environmental Risk in Alzheimer's Disease consortium (GERAD). Polygenic Hazard Scores were generated for the same individuals. The age‐specific genetic risk for AD identified by the PRS was compared with that generated by the PHS. This was repeated using varying SNP s P‐value thresholds for disease association. Results: Polygenic Risk Score significantly predicted the risk associated with age at AD onset when SNP s were preselected for association to AD at P ≤ 0.001. The strongest effect (B = 0.28,SE = 0.04,P = 2.5 × 10−12) was observed for PRS based upon genome‐wide significant SNP s (P ≤ 5 × 10−8). The strength of association was weaker with less stringent SNP selection thresholds. Interpretation: Both PRS and PHS can be used to predict an age‐specific risk for developing AD. The PHS approach uses SNP effect sizes derived with the Cox Proportional Hazard Regression model. When SNP s were selected based upon AD GWAS case/control P ≤ 10−3, we found no advantage of using SNP effects sizes calculated with the Cox Proportional Hazard Regression model in our study. When SNP s are selected for association with AD risk at P > 10−3, the age‐specific risk prediction results are not significant for either PRS or PHS. However PHS could be more advantageous than PRS of age specific AD risk predictions when SNP s are prioritized for association with AD age at onset (i.e., powerful Cox Regression GWAS study).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/acn3.716

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 95

Metadata

Authors
Leonenko, G., Sims, R., Shoai, M., Frizzati, A., Bossù, P., Spalletta, G., Fox, N. C., Williams, J., the GERAD consortium, Hardy, J., & Escott‐Price, V.
Venue
Annals of Clinical and Translational Neurology
Publisher
Wiley
Published
2019-02-18
Volume
6
Issue
3
Pages
456-465
ISSN
2328-9503 (ISSN-L)
OpenAlex
W2917906486
Cited by
95
References
10
FWCI
7.57
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polygenic risk and hazard scores for Alzheimer's disease prediction. https://app.cochat.ai/papers/10.1002/acn3.716
The paper
Leonenko, G., Sims, R., Shoai, M., Frizzati, A., Bossù, P., Spalletta, G., Fox, N. C., Williams, J., the GERAD consortium, Hardy, J., & Escott‐Price, V. (2019). Polygenic risk and hazard scores for Alzheimer's disease prediction. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.716

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.